Default: Trends in Cancer

ISSN: 2405-8033

Journal Home

Journal Guideline

Trends in Cancer Q1 Unclaimed

Cell Press United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Trends in Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 90. It has an SJR impact factor of 4,513 and it has a best quartile of Q1. It has an SJR impact factor of 4,513.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Trends in Cancer

4,513

SJR Impact factor

90

H Index

111

Total Docs (Last Year)

338

Total Docs (3 years)

7747

Total Refs

3828

Total Cites (3 years)

324

Citable Docs (3 years)

9.71

Cites/Doc (2 years)

69.79

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope





Best articles by citations

The Tumor Microenvironment Takes Center Stage in Ovarian Cancer Metastasis

View more

Rise of the Machines: Advances in Deep Learning for Cancer Diagnosis

View more

Cancer Genomics in Clinical Context

View more

WITHDRAWN: Evolutionary Game Dynamics and Cancer

View more

Lighting Up Cancer Dynamics

View more

Mechanistic Links between Obesity, Insulin, and Cancer

View more

Intrinsic versus Extrinsic Cancer Risks: The Debate Continues

View more

MicroRNAs Regulating MicroRNAs in Cancer

View more

Mutagenesis by Microbe: the Role of the Microbiota in Shaping the Cancer Genome

View more

Modeling Cancer with Pluripotent Stem Cells

View more

The New Frontiers in Cancer

View more

Tissue-Intrinsic Tumor Hotspots: Terroir for Tumorigenesis

View more
SHOW MORE ARTICLES

Identification of Antigenic Targets

View more

Epigenetic Biomarkers in Gallbladder Cancer

View more

Thermoneutrality, Mice, and Cancer: A Heated Opinion

View more

Cancer Is Not (Only) a Senescence Problem

View more

Solid Stress in Brain Tumors

View more

Brachyury: Strategies for Drugging an Intractable Cancer Therapeutic Target

View more

Metabolic Stress Triggers Immune Escape by Tumors

View more

Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors

View more

The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer

View more

Targeting the Microenvironment in Advanced Colorectal Cancer

View more

Fibroblasts Fuel Immune Escape in the Tumor Microenvironment

View more

Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells

View more

FAQS